Verxant, Secukinumab 150 mg powder for solution for injection, 1 vial — Cosentyx-equivalent Treatment for moderate to severe psoriasis Drug delivery from Europe, guaranteed storage conditions, payment upon receipt. Order by calling +380996042415, Viber, or WhatsApp.

Treatment of moderate to severe psoriasis in adult patients for whom systemic therapy or phototherapy is indicated; treatment of active psoriatic arthritis as monotherapy or in combination with methotrexate in adult patients with an inadequate response to previous therapy with disease-modifying drugs; treatment of active ankylosing spondylitis in adult patients with an inadequate response to standard therapy.

For subcutaneous administration.

Initial dose: 300 mg given as two separate subcutaneous injections of 150 mg.

The treatment regimen depends on the indication and clinical response.